Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among HIV-positive people, it is preferable to treat hepatitis B with a two-drug regimen rather than with monotherapy.
For people with hepatitis C and chronic liver disease, retreatment with interferon monotherapy is unlikely to improve their condition and may...
Three new studies have identified ways that the hepatitis C virus enters and hijacks liver cells, manipulating them to serve its own aim: repr...
People taking once-daily Norvir (ritonavir)-boosted Prezista (darunavir) monotherapy were able to maintain control over HIV for 96 week...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.